Luminex Corp - Product Pipeline Analysis, 2022 Update

Summary

Luminex Corp (Luminex) develops, manufactures and markets proprietary biological testing technologies. The company offers a wide range of products including assays, instruments, reagents and accessories, software and replacement parts. It employs proprietary technologies to test for proteins and nucleic acids, and to serve multiplexing, precision, sensitivity, accuracy, and for reduction of labor. Luminex offers its products to various markets such as pharmaceutical drug discovery; clinical diagnostics; biomedical research including personalized medicine and genomic research. The company sells its products through direct sales channel and strategic distribution partners in Asia-Pacific North America and Europe. Luminex is headquartered in Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Luminex Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Luminex Corp Company Overview
Luminex Corp Company Snapshot
Luminex Corp Pipeline Products and Ongoing Clinical Trials Overview
Luminex Corp – Pipeline Analysis Overview
Business Description
Luminex Corp - Key Facts
Luminex Corp - Major Products and Services
Luminex Corp Pipeline Products by Development Stage
Luminex Corp Ongoing Clinical Trials by Trial Status
Luminex Corp Pipeline Products Overview
ARIES - Tuberculosis Assay
ARIES - Tuberculosis Assay Product Overview
ARIES Flu A/B/RSV/SARS-CoV-2 Assay
ARIES Flu A/B/RSV/SARS-CoV-2 Assay Product Overview
Aries LDT Cartridge
Aries LDT Cartridge Product Overview
Aries V2
Aries V2 Product Overview
Atlas System - Enteric Assay
Atlas System - Enteric Assay Product Overview
Companion Diagnostic Device - Alzheimer's Disease
Companion Diagnostic Device - Alzheimer's Disease Product Overview
Diagnostic Assay - MRSA
Diagnostic Assay - MRSA Product Overview
Diagnostic Assay - RVP II
Diagnostic Assay - RVP II Product Overview
Fungal Panel Assay
Fungal Panel Assay Product Overview
LX200/FM3D Convalescent Serum - COVID-19
LX200/FM3D Convalescent Serum - COVID-19 Product Overview
LX200/FM3D Immunity Status - COVID-19
LX200/FM3D Immunity Status - COVID-19 Product Overview
Magpix - Ebola Virus Assay
Magpix - Ebola Virus Assay Product Overview
Magpix Convalescent Serum - COVID-19
Magpix Convalescent Serum - COVID-19 Product Overview
Magpix Serology Immunity Status - COVID-19
Magpix Serology Immunity Status - COVID-19 Product Overview
Magpix Syndromic Dx - COVID-19
Magpix Syndromic Dx - COVID-19 Product Overview
Meningitis Panel Assay
Meningitis Panel Assay Product Overview
NxTAG Respiratory Pathogen Panel - Expanded Version
NxTAG Respiratory Pathogen Panel - Expanded Version Product Overview
Portable Field Deployed Diagnostic Tool
Portable Field Deployed Diagnostic Tool Product Overview
Verigene I Acute Dx - COVID-19
Verigene I Acute Dx - COVID-19 Product Overview
VERIGENE I SARS-CoV-2
VERIGENE I SARS-CoV-2 Product Overview
Verigene II Acute Dx - COVID-19
Verigene II Acute Dx - COVID-19 Product Overview
Verigene II Gastrointestinal Flex Assay
Verigene II Gastrointestinal Flex Assay Product Overview
Verigene II Gastrointestinal Flex Assay Clinical Trial
Verigene II Respiratory Flex Assay
Verigene II Respiratory Flex Assay Product Overview
VERIGENE II SARS-CoV-2
VERIGENE II SARS-CoV-2 Product Overview
Verigene II Syndromic Dx - COVID-19
Verigene II Syndromic Dx - COVID-19 Product Overview
Verigene II System
Verigene II System Product Overview
Verigene II System - Blood Culture ID Assay
Verigene II System - Blood Culture ID Assay Product Overview
Verigene II System - Meningitis Panel
Verigene II System - Meningitis Panel Product Overview
Verigene II System - Syndromic Assay
Verigene II System - Syndromic Assay Product Overview
xMAP-Powered Assay - Breast Cancer
xMAP-Powered Assay - Breast Cancer Product Overview
Luminex Corp - Key Competitors
Luminex Corp - Key Employees
Luminex Corp - Key Employee Biographies
Luminex Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Luminex Corp, Recent Developments
Nov 22, 2021: RD-Biotech expands antibody and immunoassay services with xMAP Technology
Mar 09, 2021: Luminex to Participate at the 2021 Barclays Global Healthcare Conference
Feb 08, 2021: Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results
Oct 07, 2020: For COVID-19 detection and epidemiology, xMAP technology offers unique advantages
Mar 31, 2020: AdvaMed: COVID-19 test availability rapidly scales up
Mar 04, 2020: Luminex provides updates on critical efforts related to novel coronavirus
Feb 24, 2020: Luminex submits VERIGENE II Respiratory Flex Assay for FDA clearance
Feb 10, 2020: Luminex reports fourth quarter and full-year 2019 results
Jan 23, 2020: Luminex To Release Fourth Quarter and Full-Year 2019 Results After Market Close On February 10, 2020
Nov 04, 2019: Luminex Corporation reports third quarter 2019 results and submission of VERIGENE II Gastrointestinal Flex Assay to the FDA
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Luminex Corp Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Luminex Corp Pipeline Products by Equipment Type
Table 3: Luminex Corp Pipeline Products by Indication
Table 4: Luminex Corp, Key Facts
Table 5: Luminex Corp, Major Products and Services
Table 6: Luminex Corp Number of Pipeline Products by Development Stage
Table 7: Luminex Corp Pipeline Products Summary by Development Stage
Table 8: Luminex Corp Ongoing Clinical Trials by Trial Status
Table 9: Luminex Corp Ongoing Clinical Trials Summary
Table 10: ARIES - Tuberculosis Assay - Product Status
Table 11: ARIES - Tuberculosis Assay - Product Description
Table 12: ARIES Flu A/B/RSV/SARS-CoV-2 Assay - Product Status
Table 13: ARIES Flu A/B/RSV/SARS-CoV-2 Assay - Product Description
Table 14: Aries LDT Cartridge - Product Status
Table 15: Aries LDT Cartridge - Product Description
Table 16: Aries V2 - Product Status
Table 17: Aries V2 - Product Description
Table 18: Atlas System - Enteric Assay - Product Status
Table 19: Atlas System - Enteric Assay - Product Description
Table 20: Companion Diagnostic Device - Alzheimer's Disease - Product Status
Table 21: Companion Diagnostic Device - Alzheimer's Disease - Product Description
Table 22: Diagnostic Assay - MRSA - Product Status
Table 23: Diagnostic Assay - MRSA - Product Description
Table 24: Diagnostic Assay - RVP II - Product Status
Table 25: Diagnostic Assay - RVP II - Product Description
Table 26: Fungal Panel Assay - Product Status
Table 27: Fungal Panel Assay - Product Description
Table 28: LX200/FM3D Convalescent Serum - COVID-19 - Product Status
Table 29: LX200/FM3D Convalescent Serum - COVID-19 - Product Description
Table 30: LX200/FM3D Immunity Status - COVID-19 - Product Status
Table 31: LX200/FM3D Immunity Status - COVID-19 - Product Description
Table 32: Magpix - Ebola Virus Assay - Product Status
Table 33: Magpix - Ebola Virus Assay - Product Description
Table 34: Magpix Convalescent Serum - COVID-19 - Product Status
Table 35: Magpix Convalescent Serum - COVID-19 - Product Description
Table 36: Magpix Serology Immunity Status - COVID-19 - Product Status
Table 37: Magpix Serology Immunity Status - COVID-19 - Product Description
Table 38: Magpix Syndromic Dx - COVID-19 - Product Status
Table 39: Magpix Syndromic Dx - COVID-19 - Product Description
Table 40: Meningitis Panel Assay - Product Status
Table 41: Meningitis Panel Assay - Product Description
Table 42: NxTAG Respiratory Pathogen Panel - Expanded Version - Product Status
Table 43: NxTAG Respiratory Pathogen Panel - Expanded Version - Product Description
Table 44: Portable Field Deployed Diagnostic Tool - Product Status
Table 45: Portable Field Deployed Diagnostic Tool - Product Description
Table 46: Verigene I Acute Dx - COVID-19 - Product Status
Table 47: Verigene I Acute Dx - COVID-19 - Product Description
Table 48: VERIGENE I SARS-CoV-2 - Product Status
Table 49: VERIGENE I SARS-CoV-2 - Product Description
Table 50: Verigene II Acute Dx - COVID-19 - Product Status
Table 51: Verigene II Acute Dx - COVID-19 - Product Description
Table 52: Verigene II Gastrointestinal Flex Assay - Product Status
Table 53: Verigene II Gastrointestinal Flex Assay - Product Description
Table 54: Verigene II Gastrointestinal Flex Assay - A Clinical Study of Gastrointestinal (GI) Assay on VERIGENE II System in the Detection of Gastrointestinal Infections
Table 55: Verigene II Respiratory Flex Assay - Product Status
Table 56: Verigene II Respiratory Flex Assay - Product Description
Table 57: VERIGENE II SARS-CoV-2 - Product Status
Table 58: VERIGENE II SARS-CoV-2 - Product Description
Table 59: Verigene II Syndromic Dx - COVID-19 - Product Status
Table 60: Verigene II Syndromic Dx - COVID-19 - Product Description
Table 61: Verigene II System - Product Status
Table 62: Verigene II System - Product Description
Table 63: Verigene II System - Blood Culture ID Assay - Product Status
Table 64: Verigene II System - Blood Culture ID Assay - Product Description
Table 65: Verigene II System - Meningitis Panel - Product Status
Table 66: Verigene II System - Meningitis Panel - Product Description
Table 67: Verigene II System - Syndromic Assay - Product Status
Table 68: Verigene II System - Syndromic Assay - Product Description
Table 69: xMAP-Powered Assay - Breast Cancer - Product Status
Table 70: xMAP-Powered Assay - Breast Cancer - Product Description
Table 71: Luminex Corp, Key Employees
Table 72: Luminex Corp, Key Employee Biographies
Table 73: Luminex Corp, Other Locations
Table 74: Luminex Corp, Subsidiaries
Table 75: Glossary
List of Figures
Figure 1: Luminex Corp Pipeline Products by Equipment Type
Figure 2: Luminex Corp Pipeline Products by Development Stage
Figure 3: Luminex Corp Ongoing Clinical Trials by Trial Statuse

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings